25-Hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: Case-control versus nested case-control studies

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 1153-1160

  Grant, William B ^a  

^a Sunlight Nutrition and Health Research Center (SUNARC)   (United States)

Author keywords

Breast cancer; Case control study; Colorectal adenoma; Colorectal cancer; Nested case control study; Vitamin D

Indexed keywords

25-HYDROXYVITAMIN D; VITAMIN D;

ADENOMA; ANALOGS AND DERIVATIVES; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; FEMALE; HUMAN;

ADENOMA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; VITAMIN D;

EID: 84922901371     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Colston KW, Berger U and Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1(8631): 188-191, 1989.
2. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK and Gorham ED: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2(8673): 1176-1178, 1989.
3. Garland FC, Garland CF, Gorham ED and Young JF: Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19(6): 614-622, 1990.
4. Moukayed M and Grant WB: Molecular link between vitamin D and cancer prevention. Nutrients 5(10): 3993-4021, 2013.
5. Grant WB: The role of animal products and vitamin D in risk of breast cancer. Nutr Clin Pract 28(1): 140, 2013.
6. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6): 1414-1424, 2011.
7. Yin L, Grandi N, Raum E, Haug U, Arndt V and Brenner H: Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12): 2196-2205, 2010.
8. Bauer SR, Hankinson SE, Bertone-Johnson ER and Ding EL: Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92(3): 123-131, 2013.
9. Chen P, Li M, Gu X, Liu Y, Li X, Li C, Wang Y, Xie D, Wang F, Yu C, Li J, Chen X, Chu R, Zhu J, Ou Z and Wang H: Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS One 8(1): e49312, 2013.
10. Wang D, Velez de-la-Paz OI, Zhai JX and Liu DW: Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol 34(6): 3509-3517, 2013.
11. Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN and Goodman MT: Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer 14: 29, 2014.
12. Kim Y and Je Y: Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 110(11): 2772-2784, 2014.
13. Tretli S, Schwartz GG, Torjesen PA and Robsahm TE: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23(2): 363-370, 2012.
14. Toriola AT, Nguyen N, Scheitler-Ring K and Colditz GA: Circulating 25-hydroxyvitamin D levels and prognosis among cancer patients: a systematic review. Cancer Epidemiol Biomarkers Prev 23(6): 917-933, 2014.
15. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85(6): 1586-1591, 2007.
16. Bolland MJ, Grey A, Gamble GD and Reid IR: Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94(4): 1144-1149, 2011.
17. Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, Parsons JK, Wingard DL and Garland CF: Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinol 4(2): 152-157, 2012.
18. Grant WB: An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 65(9): 1016-1026, 2011.
19. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG and Colston KW: Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41(8): 1164-1169, 2005.
20. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D and Chang-Claude J: Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study. Carcinogenesis 29(1): 93-99, 2008.
21. Abbas S, Chang-Claude J and Linseisen J: Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 124(1): 250-255, 2009.
22. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D and Hershman DL: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27(13): 2151-2156, 2009.
23. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL and Ambrosone CB: Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 6(2): e17251, 2011.
24. Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L and Mosekilde L: Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 18(10): 2655-2660, 2009.
25. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC and Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14(8): 1991-1997, 2005.
26. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ and Calle EE: Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res 11(4): R64, 2009.
27. Chlebowski RT: Vitamin D and breast cancer incidence and outcome. Anticancer Agents Med Chem 13(1): 98-106, 2013.
28. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD and Ziegler RG: Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17(4): 889-894, 2008.
29. Kuhn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, Dossus L, Tjonneland A, Olsen A, Overvad K, Chang-Claude J, Lukanova A, Buijsse B, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Krogh V, Sacerdote C, Tumino R, Mattiello A, Buckland G, Sanchez MJ, Menendez V, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Bakker MF, Weiderpass E, Skeie G, Brustad M, Andersson A, Sund M, Wareham N, Khaw KT, Travis RC, Schmidt JA, Rinaldi S, Romieu I, Gallo V, Murphy N, Riboli E and Linseisen J: Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer 133(7): 1689-1700, 2013.
30. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldana-Quiroz VA and Romieu I: Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23(7): 1149-1162, 2012.
31. Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR and Skinner KA: The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol 19(8): 2590-2599, 2012.
32. Bilinski K and Boyages J: Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res Treat 137(2): 599-607, 2013.
33. Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, Parsons JK, Wingard DL, Horst R and Garland CF: Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum. Cancer Causes Control 24(3): 495-504, 2013.
34. Yousef FM, Jacobs ET, Kang PT, Hakim IA, Going S, Yousef JM, Al-Raddadi RM, Kumosani TA and Thomson CA: Vitamin D status and breast cancer in Saudi Arabian women: case-control study. Am J Clin Nutr 98(1): 105-110, 2013.
35. Yin L, Grandi N, Raum E, Haug U, Arndt V and Brenner H: Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30(2): 113-125, 2009.
36. Yaylim-Eraltan I, Arzu Ergen H, Arikan S, Okay E, Ozturk O, Bayrak S and Isbir T: Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct 25(6): 731-737, 2007.
37. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN and Le Marchand L: Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19(1): 130-134, 2010.
38. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodriguez L, Sanchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P and Riboli E: Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 340: b5500, 2010.
39. Wu-Wong JR, Nakane M, Ma J, Ruan X and Kroeger PE: VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. J Cell Biochem 100(6): 1395-1405, 2007.
40. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J and Albanes D: Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8(4): 615-625, 1997.
41. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW and Giovannucci EL: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13(9): 1502-1508, 2004.
42. Otani T, Iwasaki M, Sasazuki S, Inoue M and Tsugane S: Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 97(3): 446-451, 2007.
43. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC and Manson JE: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354(7): 684-696, 2006.
44. Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, Xue S, Lee ER, Frankel HD and Haile RW: Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 39(1): 35-41, 2001.
45. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N and Sinha R: Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10(12): 1267-1274, 2001.
46. Fedirko V, Bostick RM, Goodman M, Flanders WD and Gross MD: Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol 172(5): 489-500, 2010.
47. Takahashi R, Mizoue T, Otake T, Fukumoto J, Tajima O, Tabata S, Abe H, Ohnaka K and Kono S: Circulating vitamin D and colorectal adenomas in Japanese men. Cancer Sci 101(7): 1695-1700, 2010.
48. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE and Giovannucci E: Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9(10): 1059-1065, 2000.
49. Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW and McGlynn KA: Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 13(4): 546-552, 2004.
50. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA and Martinez ME: Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol 103(3-5): 752-756, 2007.
51. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR and Heber D: Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95(23): 1765-1771, 2003.
52. 2 laser, radiowave radiosurgery, skin biopsy punch, and scalpel. Vet Surg 36(1): 50-56, 2007.
53. Grant WB: Re: "The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women". Am J Epidemiol 176(9): 838, 2012.
54. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Roswall N, Larsen SC and Linneberg A: Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev 23(7): 1220-1229, 2014.
55. Oh EY, Ansell C, Nawaz H, Yang CH, Wood PA and Hrushesky WJ: Global breast cancer seasonality. Breast Cancer Res Treat 123(1): 233-243, 2010.
56. McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H and Crawford DH: HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 117(10): 3042-3048, 2007.
57. Carvalho B, Sillars-Hardebol AH, Postma C, Mongera S, Terhaar Sive Droste J, Obulkasim A, van de Wiel M, van Criekinge W, Ylstra B, Fijneman RJ and Meijer GA: Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism. Cell Oncol (Dordr) 35(1): 53-63, 2012.
58. Giovannucci E: Epidemiology of vitamin D and colorectal cancer. Anticancer Agents Med Chem 13(1): 11-19, 2013.
59. Wei MY, Garland CF, Gorham ED, Mohr SB and Giovannucci E: Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(11): 2958-2969, 2008.
60. Boscoe FP and Schymura MJ: Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 6: 264, 2006.
61. Grant WB: Role of solar UVB irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Dermatoendocrinol 4(2): 203-211, 2012.
62. Chen W, Clements M, Rahman B, Zhang S, Qiao Y and Armstrong BK: Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 21(10): 1701-1709, 2010.
63. Astbury A. Cancer mortality, cosmic ray neutron dose, and summer solar UV-B flux share similar geographical distributions in the USA.Triumf report TRI-PP-05-24. June 2005
64. Grant WB: Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 32(1): 223-236, 2012.
65. Mizoue T: Ecological study of solar radiation and cancer mortality in Japan. Health Phys 87(5): 532-538, 2004.
66. Grant WB and Boucher BJ: Are Hill's criteria for causality satisfied for vitamin D and periodontal disease? Dermatoendocrinol 2(1): 30-36, 2010.
67. Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94(6): 1867-1875, 2002.
68. Grant WB and Garland CF: The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26(4A): 2687-2699, 2006.
69. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB and Franco OH: Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348: g1903, 2014.
70. Grant WB and Garland CF: Vitamin D has a greater impact on cancer mortality rates than on cancer incidence rates. BMJ 348: g2862, 2014.
71. Rebel H, der Spek CD, Salvatori D, van Leeuwen JP, Robanus-Maandag EC and de Gruijl FR: UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine-specific Apc mutant mice kept on low vitamin D diet. Int J Cancer, 2014.
72. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9(3): 227-231, 1980.
73. Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, Brouckaert O, Peuteman G, Laenen A, Verlinden L, Kriebitzsch C, Dieudonne AS, Paridaens R, Neven P, Christiaens MR, Bouillon R and Wildiers H: Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33(7): 1319-1326, 2012.
74. Villasenor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A and Neuhouser ML: Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 24(4): 759-767, 2013.
75. Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, Flesch-Janys D and Chang-Claude J: Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Int J Cancer 134(12): 2972-2983, 2014.
76. Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23): 3757-3763, 2009.
77. Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, Leroy EC, Newman VA, Parker BA, Rock CL and Pierce JP: Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr 93(1): 108-117, 2011.
78. Heaney RP: Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72(1): 48-54, 2014.